Literature DB >> 15320724

Inhibitors of 3C cysteine proteinases from Picornaviridae.

Manjinder S Lall1, Rajendra P Jain, John C Vederas.   

Abstract

The Picornaviridae are among the smallest icosahedral positive-sense single stranded RNA containing viruses known, and comprise one of the largest and most important families of human and animal pathogens. The hepatitis A virus (HAV) and human rhinovirus (HRV) are important pathogens that belong to the picornavirus family. All picornaviruses have a 3C proteinase that processes an initially biosynthesized precursor protein and is crucial for viral maturation and replication. Although it is a cysteine proteinase, this 3C enzyme has a topology similar to those of the chymotrypsin-like serine proteinases. A series of inhibitors of HAV and HRV 3C proteinases were synthesized and tested as potential lead compounds for the design of therapeutic agents for human picornaviral pathogens. This research shows that thiol-reactive groups or "warheads" such as iodoacetamides, beta-lactones, Michael acceptors, ketones and pseudoxazolones can be used as effective tools to inhibit the HAV and HRV 3C proteinase enzymes. In addition, studies based on enzyme-inhibitor kinetics, mass spectrometry and NMR spectroscopy were effectively used to gain knowledge concerning enzyme-inhibitor mechanism of action and enzyme-inhibitor regiospecific reactivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15320724     DOI: 10.2174/1568026043387836

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  11 in total

Review 1.  Nitric oxide and redox mechanisms in the immune response.

Authors:  David A Wink; Harry B Hines; Robert Y S Cheng; Christopher H Switzer; Wilmarie Flores-Santana; Michael P Vitek; Lisa A Ridnour; Carol A Colton
Journal:  J Leukoc Biol       Date:  2011-01-13       Impact factor: 4.962

2.  Coxsackievirus B3 protease 3C: expression, purification, crystallization and preliminary structural insights.

Authors:  Stavroula Fili; Alexandros Valmas; Magdalini Christopoulou; Maria Spiliopoulou; Nikos Nikolopoulos; Julie Lichière; Souzana Logotheti; Fotini Karavassili; Eleftheria Rosmaraki; Andrew Fitch; Jonathan Wright; Detlef Beckers; Thomas Degen; Gwilherm Nénert; Rolf Hilgenfeld; Nicolas Papageorgiou; Bruno Canard; Bruno Coutard; Irene Margiolaki
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-11-25       Impact factor: 1.056

3.  DWV 3C Protease Uncovers the Diverse Catalytic Triad in Insect RNA Viruses.

Authors:  Xuye Yuan; Tatsuhiko Kadowaki
Journal:  Microbiol Spectr       Date:  2022-05-16

4.  Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection.

Authors:  Xiao-Nan Zhang; Zhi-Gang Song; Ting Jiang; Bi-Sheng Shi; Yun-Wen Hu; Zheng-Hong Yuan
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

Review 5.  Autoproteolytic activation of bacterial toxins.

Authors:  Aimee Shen
Journal:  Toxins (Basel)       Date:  2010-05-06       Impact factor: 4.546

Review 6.  Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus.

Authors:  Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Masato Nakamura; Xia Jiang; Yuki Haga; Reina Sasaki; Osamu Yokosuka
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

7.  Assessing activity of Hepatitis A virus 3C protease using a cyclized luciferase-based biosensor.

Authors:  Junwei Zhou; Dang Wang; Yongqiang Xi; Xinyu Zhu; Yuting Yang; Mengting Lv; Chuanzhen Luo; Jiyao Chen; Xu Ye; Liurong Fang; Shaobo Xiao
Journal:  Biochem Biophys Res Commun       Date:  2017-05-10       Impact factor: 3.575

Review 8.  Molecular biology and inhibitors of hepatitis A virus.

Authors:  Yannick Debing; Johan Neyts; Hendrik Jan Thibaut
Journal:  Med Res Rev       Date:  2013-05-30       Impact factor: 12.944

9.  QM/QM studies for Michael reaction in coronavirus main protease (3CL Pro).

Authors:  Alex G Taranto; Paulo Carvalho; Mitchell A Avery
Journal:  J Mol Graph Model       Date:  2008-05-09       Impact factor: 2.518

Review 10.  The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.

Authors:  Judith M Rollinger; Michaela Schmidtke
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.